GlassScriptPhysician profile
Elizabeth E Baylor
NPI 1235615899
$6,333.25
in general payments reported to CMS, 2019-2025
19 companies · $490 in 2025
The $490 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,714 · 2020: $592 · 2021: $312 · 2022: $715 · 2023: $433 · 2024: $78.16 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,687.64 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $1,153.55 | 2019 | |
| Bausch & Lomb Americas INC. | $679.33 | 2022-2025 | Infuse, Miebo, Biotrue |
| Alcon Vision LLC | $536.36 | 2019-2025 | Dailies Total1, Tryptyr, Total30 |
| Johnson & Johnson Vision Care, INC. | $359.48 | 2019-2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $197.14 | 2020-2023 | Cequa |
| Alimera Sciences, INC. | $163.69 | 2019 | |
| Aerie Pharmaceuticals, INC. | $148.87 | 2021 | |
| Optos, INC. | $125.48 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $60.28 | 2023 | Acthar |
| Coopervision INC. | $39.95 | 2022-2023 | Paragon Crt |
| Shire North American Group INC | $35.18 | 2019 | |
| Biotissue Holdings INC. | $30.57 | 2021-2022 | |
| Oyster Point Pharma, INC. | $28.93 | 2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $22.22 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.75 | 2022 | |
| Abbvie INC. | $16.79 | 2022 | |
| Harrow Eye, LLC | $15.10 | 2024 | Vevye |
| Allergan, INC. | $14.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Baylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.